387 related articles for article (PubMed ID: 11253504)
41. [Extraintestinal manifestations of inflammatory bowel disease].
Rogler G; Schölmerich J
Med Klin (Munich); 2004 Mar; 99(3):123-30. PubMed ID: 15024484
[TBL] [Abstract][Full Text] [Related]
42. Presentation and management outcome of inflammatory bowel disease in Sudan.
Khalifa SE; Mudawi HM; Fedail SS
Trop Gastroenterol; 2005; 26(4):194-6. PubMed ID: 16737049
[TBL] [Abstract][Full Text] [Related]
43. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
Barreiro-de Acosta M; Domínguez-Muñoz JE; Núñez-Pardo de Vera MC; Lozano-León A; Lorenzo A; Peña S
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
[TBL] [Abstract][Full Text] [Related]
44. [Inflammatory intestinal diseases and their extra-intestinal manifestations observed at Liban].
Ghayad E; Haddad F; el Aam C; Tohmé A; Nasr W
J Med Liban; 1997 Dec; 45(4):191-6. PubMed ID: 9747008
[TBL] [Abstract][Full Text] [Related]
45. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
[TBL] [Abstract][Full Text] [Related]
46. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
47. [Chronic inflammatory bowel diseases. Dermatoses and joint pain can be the initial symptoms].
Stiefelhagen P
MMW Fortschr Med; 2003 Apr; 145(17):14. PubMed ID: 12808794
[No Abstract] [Full Text] [Related]
48. [Epidemiology of inflammatory bowel diseases in Veszprém county of Western Hungary between 1977 and 2001].
Lakatos L; Mester G; Erdélyi Z; Balogh M; Szipócs I; Kamarás G; Lakatos PL
Orv Hetil; 2003 Sep; 144(37):1819-27. PubMed ID: 14596020
[TBL] [Abstract][Full Text] [Related]
49. Capsule endoscopy may reclassify pediatric inflammatory bowel disease: a historical analysis.
Cohen SA; Gralnek IM; Ephrath H; Saripkin L; Meyers W; Sherrod O; Napier A; Gobin T
J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):31-6. PubMed ID: 18607266
[TBL] [Abstract][Full Text] [Related]
50. [Chronic inflammatory diseases of the intestine. Extra-intestinal manifestations and perianal complications].
Lorusso D; Leo S; Lacitignola S; Tarantino S
Minerva Dietol Gastroenterol; 1989; 35(1):17-21. PubMed ID: 2725924
[TBL] [Abstract][Full Text] [Related]
51. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients.
Mir-Madjlessi SH; Taylor JS; Farmer RG
Am J Gastroenterol; 1985 Aug; 80(8):615-20. PubMed ID: 4025277
[TBL] [Abstract][Full Text] [Related]
52. [Metastatic Crohn's disease in childhood].
González Gómez JM; Sierra Salinas C; Alonso Usabiaga I; Barco Gálvez A; del Río Mapelli L; García Lorenzo C
An Esp Pediatr; 2001 Aug; 55(2):165-8. PubMed ID: 11472671
[TBL] [Abstract][Full Text] [Related]
53. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.
Zippi M; Corrado C; Pica R; Avallone EV; Cassieri C; De Nitto D; Paoluzi P; Vernia P
World J Gastroenterol; 2014 Dec; 20(46):17463-7. PubMed ID: 25516659
[TBL] [Abstract][Full Text] [Related]
54. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease.
Ciccacci C; Biancone L; Di Fusco D; Ranieri M; Condino G; Giardina E; Onali S; Lepre T; Pallone F; Novelli G; Borgiani P
J Crohns Colitis; 2013 Feb; 7(1):44-52. PubMed ID: 22445837
[TBL] [Abstract][Full Text] [Related]
55. Orthopaedic experience on inflammatory bowel disease (Lesniowski-Crohn's disease and ulcerative colitis).
Geraci A; Tomasello G; Sabetta SP
Ortop Traumatol Rehabil; 2010; 12(5):430-4. PubMed ID: 21057150
[TBL] [Abstract][Full Text] [Related]
56. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management.
Larsen S; Bendtzen K; Nielsen OH
Ann Med; 2010 Mar; 42(2):97-114. PubMed ID: 20166813
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP
Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969
[TBL] [Abstract][Full Text] [Related]
58. Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations.
He R; Zhao S; Cui M; Chen Y; Ma J; Li J; Wang X
Front Immunol; 2023; 14():1234535. PubMed ID: 37954590
[TBL] [Abstract][Full Text] [Related]
59. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
Isene R; Bernklev T; Høie O; Munkholm P; Tsianos E; Stockbrügger R; Odes S; Palm Ø; Småstuen M; Moum B;
Scand J Gastroenterol; 2015 Mar; 50(3):300-5. PubMed ID: 25535653
[TBL] [Abstract][Full Text] [Related]
60. [Patients with inflammatory bowel disease in specialist gastroenterology practice: a prospective survey].
Beltinger J; Froehlich F;
Praxis (Bern 1994); 2005 Mar; 94(12):459-65. PubMed ID: 15846950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
